61 results
424B3
ACST
Acasti Pharma Inc - Ordinary Shares
16 Oct 23
Prospectus supplement
4:31pm
is required to include such proposal in the information circular pertaining to any annual meeting at which it solicits proxies, subject to certain
DEFA14A
ACST
Acasti Pharma Inc - Ordinary Shares
25 Aug 23
Additional proxy soliciting materials
4:21pm
described in the Corporation’s management information circular and proxy statement. PLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your
8-K
EX-99.2
8jtr8phccl
27 Aug 21
Completion of Acquisition or Disposition of Assets
8:47am
8-K
EX-99.1
0d7altt5pjg4
27 Aug 21
Completion of Acquisition or Disposition of Assets
8:47am
424B3
0hohswcdp9c44tdmse4
15 Jul 21
Prospectus supplement
4:45pm
S-4
EX-99.2
utn3u6 1uzpfuuz
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
S-4
ad833iv6
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-2.1
e5ce4shgb5udzaafzp
7 May 21
Entry into a Material Definitive Agreement
7:09am
8-K
7byha 0msz82
7 May 21
Entry into a Material Definitive Agreement
7:09am
8-K
EX-10.1
36he d9akeck
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
wiyoet bj74d6pc1zn
7 May 21
Business combination disclosure
7:08am
425
EX-2.1
v6q0mcg
7 May 21
Business combination disclosure
7:08am
425
EX-10.1
xan cydhoqjzpulpd8
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
qbmd6z8
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm